SYMPOSIUM: Vasopressin-Regulated Transporters in the Urinary Concentration Mechanism

Regulation of Renal Urea Transporters

JEFF M. SANDS
JASN March 1999, 10 (3) 635-646;

Abstract

Abstract. Urea is important for the conservation of body water due to its role in the production of concentrated urine in the renal inner medulla. Physiologic data demonstrate that urea is transported by facilitated and by active urea transporter proteins. The facilitated urea transporter (UT-A) in the terminal inner medullary collecting duct (IMCD) permits very high rates of transepithelial urea transport and results in the delivery of large amounts of urea into the deepest portions of the inner medulla where it is needed to maintain a high interstitial osmolality for concentrating the urine maximally. Four isoforms of the UT-A urea transporter family have been cloned to date. The facilitated urea transporter (UT-B) in erythrocytes permits these cells to lose urea rapidly as they traverse the ascending vasa recta, thereby preventing loss of urea from the medulla and decreasing urine-concentrating ability by decreasing the efficiency of countercurrent exchange, as occurs in Jk null individuals (who lack Kidd antigen). In addition to these facilitated urea transporters, three sodium-dependent, secondary active urea transport mechanisms have been characterized functionally in IMCD subsegments: (1) active urea reabsorption in the apical membrane of initial IMCD from low-protein fed or hypercalcemic rats; (2) active urea reabsorption in the basolateral membrane of initial IMCD from furosemide-treated rats; and (3) active urea secretion in the apical membrane of terminal IMCD from untreated rats. This review focuses on the physiologic, biophysical, and molecular evidence for facilitated and active urea transporters, and integrative studies of their acute and long-term regulation in rats with reduced urine-concentrating ability.

Urea is important for the conservation of body water due to its role in the production of concentrated urine in the renal inner medulla. The passive mechanism hypothesis for urine concentration in the inner medulla, proposed by Kokko and Rector (1) and by Stephenson (2) in 1972, requires the delivery of large quantities of urea to the deepest portions of the inner medullary (papillary) interstitium. This is accomplished through the transport of urea via the vasopressin-regulated urea transporter (UT-A1) (Table 1) in terminal inner medullary collecting duct (IMCD) (3, 4). In addition, the erythrocyte urea transporter (UT-B) (Table 1) minimizes the loss of urea from the inner medulla by increasing the efficiency of countercurrent exchange for urea in the vasa recta (5). Thus, the production of concentrated urine and the conservation of body water depend on urea transporters in both IMCD and erythrocytes.

View this table:
Table 1.

Comparison of cloned facilitated urea transportersa

Urea also serves a second function in the kidney: the excretion of nitrogenous waste. Because large quantities of urea need to be excreted daily, the kidney's ability to concentrate urea reduces the need to excrete water simply to remove nitrogenous waste. Urea within the collecting duct lumen can be balanced osmotically by a high interstitial urea concentration. If interstitial urea were unavailable to offset the osmotic effect of urea in the collecting duct lumen that was destined for excretion, then the interstitial NaCl concentration would need to be much higher, necessitating an increase in NaCl reabsorption from thick ascending limbs with an accompanying increase in work (ATP consumption). This effect of urea led to Gamble and colleague's 1934 observation that there is “an economy of water in renal function referable to urea” (6).

The reader may wonder why collecting ducts or erythrocytes need urea transporters when most textbooks state that urea is freely permeable and equilibrates across cell membranes. Urea is a small molecule with a molecular weight of 60 Da that will diffuse across cell membranes and achieve equilibrium given enough time since it is not completely impermeable. However, urea is a highly polar molecule (O = C(-NH2)2) and has a low permeability through artificial lipid bilayers (4 × 10-6 cm/s) (7) that lack any transport proteins to facilitate its transfer. The transit time for tubule fluid through the collecting duct or for erythrocytes through the vasa recta is too rapid for urea to achieve equilibrium by simple lipid-phase diffusion or paracellular transport. Thus, both IMCD and erythrocytes require urea transporters to transport urea rapidly enough to produce concentrated urine. Additionally, regulated urea transport processes are needed to concentrate urea within the deepest portions of the inner medullary interstitium to maintain the urea gradient that is critical for the production of concentrated urine (1, 2).

This review focuses on the physiologic, biophysical, and molecular evidence for facilitated and active urea transporters, and integrative studies of their acute and long-term regulation in rats with reduced urine concentrating ability. The reader is referred to other reviews of urea transport for areas not covered herein (8,9,10,11).

Facilitated Urea Transport

Although several early studies suggested that vasopressin could increase urea permeability across IMCD in mammals (12,13,14,15), direct evidence was not obtained until the late 1980s when three groups showed that vasopressin could increase passive urea permeability in isolated perfused rat IMCD (4, 16, 17). Rat terminal IMCD have a high basal urea permeability that is increased 400% after stimulation by vasopressin (3, 4, 18, 19). This high urea permeability, especially after stimulation by vasopressin, was the first evidence that terminal IMCD contained a facilitated (or carrier-mediated) urea transporter (4). Even in the absence of vasopressin, rat terminal IMCD have a urea permeability that is 85 times greater than the calculated maximal urea permeability which could be achieved by simple lipid-phase diffusion and paracellular transport (4).

Physiologic Evidence for Facilitated Urea Transport

Urea transport by a facilitated or carrier-mediated transporter in the mammalian collecting duct was first proposed in 1987 (4). Before this proposal, two other mechanisms to increase urea delivery to the deepest portions of the inner medullary interstitium had been suggested: (1) urea reabsorption across the papillary surface epithelium (20); and (2) urea reabsorption by solvent drag through aqueous pores in IMCD (20,21,22,23,24,25,26). However, subsequent experimental studies showed that neither of these proposed mechanisms makes a significant contribution to urea delivery into the inner medulla.

The papillary surface epithelium has a low urea permeability, even with vasopressin present, precluding significant urea reabsorption across it (3). Solvent drag of urea, i.e., urea and water sharing a common transport pathway and physically interacting in the pathway or pore, is determined by measuring the reflection coefficient for urea (σu = 1 - Pu/Pw). Early studies (13, 16, 27) did measure a reflection coefficient for urea of less than 1, suggesting the presence of solvent drag of urea. However, more recent studies remeasured the reflection coefficient for urea in rat terminal IMCD, including explicit measurement of the dissipation of the imposed urea gradient, and showed that the urea reflection coefficients is 1, i.e., no solvent drag of urea (28, 29). Other experimental findings also preclude solvent drag of urea: (1) in terminal IMCD, phloretin inhibits urea transport, but not water transport, consistent with urea and water transport occurring by separate pathways (17, 30); and (2) in Xenopus oocytes, heterologously expressed aquaporin-2 (AQP2), the vasopressin-regulated water channel, is impermeable to urea, whereas UT-A1, the vasopressin-regulated urea transporter, is impermeable to water (31, 32). Thus, there are no experimental data to support either significant recycling of urea across the papillary surface epithelium or solvent drag of urea across terminal IMCD.

It should be noted that solvent drag is not required for perfused terminal IMCD to reabsorb water. A significant rate of fluid reabsorption occurs when rat terminal IMCD are perfused in the absence of an osmotic gradient but with a bath solution that is higher in NaCl and a perfusate solution that is higher in urea, due to rapid facilitated urea reabsorption, down its chemical gradient, generating an osmotic gradient for water reabsorption (29). Thus, rat terminal IMCD can perform osmotic work, even without solvent drag, by the combination of a high luminal urea concentration and a high rate of facilitated urea transport.

Inhibitor studies provided additional evidence for the concept of a facilitated urea transporter. As mentioned above, phloretin, an inhibitor of facilitated urea transport in erythrocytes (33, 34), inhibits urea transport (but not osmotic water permeability) in terminal IMCD (17, 30, 35). In addition, urea analogs, such as thiourea, inhibit urea transport in terminal IMCD (30, 35). Chou and colleagues used thiourea to test for saturation kinetics in perfused terminal IMCD and showed saturation of the facilitated urea transporter with a Km of 20 mM thiourea (36). They also showed that the Km for urea itself exceeded 800 mM urea; technical problems precluded their study of higher urea concentrations (36). Kishore and colleagues estimated a facilitated urea transporter turnover number of 0.3 to 1 × 10-5, suggesting that the facilitated urea transporter is a channel rather than a carrier (37).

Molecular Cloning of the Kidney-Facilitated Urea Transporter: UT-A

The preceding physiologic studies established the existence of, and provided a functional definition for, a facilitated urea transporter in mammalian terminal IMCD. On the basis of this definition, Hediger and colleagues expression-cloned UT-A2 (Table 1), a putative vasopressin-regulated urea transporter, from rabbit inner medulla (31). Subsequently, UT-A2 homologs from human and rat were cloned; they share 90% sequence identity with rabbit UT-A2 (38,39,40,41). Heterologous expression of UT-A2 cRNA in Xenopus oocytes results in a urea flux that can be inhibited by phloretin and urea analogs (31, 38, 39, 42), consistent with the functional properties of the facilitated urea transporter in rat terminal IMCD (30). In contrast to rat terminal IMCD (43, 44), cAMP analogs have no effect on urea flux in Xenopus occytes (31, 45) or human embryonic kidney cells (HEK-293 cells) that heterologously express UT-A2 (31, 45, 46), suggesting that UT-A2 is not a vasopressin-regulated urea transporter.

Northern analysis of rat or rabbit inner medullary mRNA using a UT-A2 cDNA probe reveals two mRNA bands at 4.0 (UT-A1) and 2.9 (UT-A2) kb (31, 38, 40, 41). You and colleagues initially published that both mRNA transcripts contained a single coding region for a single protein (31). Their next publication reported that these two mRNA bands were splice variants of a single gene with identical 3′ ends but differing at their 5′ ends so that splicing of the 4.0-kb mRNA produces an additional 1.6 kb of coding region (45). However, they did not clone the gene or provide any evidence that UT-A1 and UT-A2 originate from alternative splicing (45). Shayakul and colleagues reserved the name “UT2” (UT-A2, Table 1) for the 2.9-kb mRNA and renamed the 4.0-kb mRNA as “UT1” (UT-A1, Table 1) (45). Heterologous expression of UT-A1 in Xenopus oocytes results in a phloretin-inhibitable urea flux that is stimulated by vasopressin (45). The two UT-A transcripts localize to different regions of the medulla: the 4.0-kb UT-A1 mRNA is the predominant transcript in terminal IMCD, whereas the 2.9-kb UT-A2 mRNA is the predominant transcript in thin descending limbs (31, 38, 40, 41, 47).

Recently, two additional cDNA representing new UT-A isoforms have been cloned: UT-A3 and UT-A4 (46). Both UT-A3 and UT-A4 mRNA are present in rat medulla but not in cortex (46). Heterologous expression of UT-A3 or UT-A4 in HEK-293 cells results in phloretin-inhibitable urea transport, which is increased by cAMP, suggesting that both UT-A3 and UT-A4 may be regulated by vasopressin (46). Naruse and colleagues have cloned the rat UT-A gene and mapped its intron/exon boundaries (48). UT-A3 and UT-A4 are likely to arise from alternative splicing of this rat UT-A gene since the 5′ end of rat UT-A1 is identical to the 5′ end of UT-A3 and UT-A4; UT-A2 has a unique 5′ end (45, 46). In addition, the 3′ end of rat UT-A1 is identical to the 3′ end of UT-A2 and UT-A4; UT-A3 has a unique 3′ end (45, 46). The human UT-A gene is located on chromosome 18q12.1-q21.1 (39).

UT-A Urea Transporter Proteins

Polyclonal antibodies to rat UT-A1 have been made by immunizing rabbits with synthetic polypeptides to the C terminus (49, 50) or the intracellular loop region of UT-A1 (11, 51). Western blots of inner medullary tip proteins generally show bands at 97 and 117 kD using either anti-UT-A1 antibody (49,50,51); both the 97- and 117-kD proteins appear to represent glycosylated versions of UT-A1 (52). UT-A1 protein is most abundant in the inner medullary tip, present in the inner medullary base, and not present in outer medulla or cortex (49, 53), consistent with the pattern of urea permeabilities measured in perfused rat collecting duct segments (3, 4, 18, 19). However, the amount of UT-A1 + UT-A2 + UT-A4 protein per millimeter tubule length does not vary between IMCD1, IMCD2, and IMCD3 subsegments when it is measured by enzyme-linked immunosorbent assay of microdissected tubules (37).

Functional studies show that phloretin-inhibitable urea transport is present in both the apical and basolateral membranes of rat terminal IMCD, with the apical membrane being the rate-limiting barrier for vasopressin-stimulated urea transport (54). UT-A1 immunostaining is observed in the apical plasma membrane and intracellular cytoplasmic vesicles of terminal IMCD, but no immunostaining is seen in the basolateral plasma membrane (49). Recently, Wade and colleagues identified a 67-kD UT-A protein in the basolateral membrane of rat terminal IMCD, suggesting that this novel UT-A protein is the basolateral membrane urea transporter (55). Although UT-A1 has an immunolocalization pattern that is similar to AQP2 (56), the question of whether regulated trafficking of UT-A1 occurs is currently controversial (57, 58). UT-A2 protein is expressed in terminal portions of short-looped thin descending limbs in the inner stripe of the rat outer medulla (49).

Molecular Cloning of Erythrocyte-Facilitated Urea Transporter: UT-B

Human UT-B1 (Table 1) was cloned by homology from UT-A2 and is the erythrocyte-facilitated urea transporter; they share 63% sequence identity (59). Heterologous expression of UT-B1 in Xenopus oocytes results in a urea flux that is inhibitable by phloretin, thiourea, and p-chloromercuriphenylsulfonate (42, 59). The rat homologs (UT-B1, UT-B2, Table 1) of human UT-B1 have been cloned (60, 61), and their mRNA are expressed in the inner stripe of outer medulla and in inner medulla (41, 61). UT-B2 mRNA abundance correlates with urine osmolality in rat inner medulla (41). UT-B1 and/or UT-B2 protein is expressed in vasa recta endothelial cells (62), suggesting that UT-B1 and/or UT-B2 may be responsible for the phloretin-inhibitable urea transport measured in perfused rat descending vasa recta (63,64,65).

The human UT-B gene is located on the same locus (chromosome 18q12.1-q21.1) as the human UT-A gene and the human Kidd antigen blood group (a minor blood group) locus (39, 66, 67). Erythrocytes from individuals lacking the Kidd antigen (Jk(a-b-) or Jk null) lack facilitated urea transport and are unable to concentrate their urine above 800 mosmol/kg H2O (68, 69). The mechanism by which loss of the erythrocyte urea transporter UT-B1 could result in a mild urine-concentrating defect is as follows: (1) erythrocytes acquire urea as they traverse the descending vasa recta into the inner medulla; (2) the loss of facilitated urea transport prevents Jk null erythrocytes from losing urea rapidly as they traverse the ascending vasa recta (5); and (3) urea is trapped in the Jk null erythrocytes and lost from the medulla when these erythrocytes return to the systemic circulation. Thus, the efficiency of countercurrent exchange is diminished, decreasing urine concentrating ability.

Active Urea Transport

Lassiter and colleagues showed that the urea concentration was greater in vasa recta than in adjacent collecting ducts in rats fed a low-protein diet or undergoing an osmotic diuresis, consistent with active transport of urea out of collecting ducts (70). Papillary micropuncture studies also supported active urea reabsorption from collecting ducts of low-protein fed rats (71, 72). Active urea transport processes have been described in a variety of tissues, including: (1) a sodium-linked, active urea transport process in the renal tubule of the spiny dogfish Squalus acanthias (73); (2) phloretin-inhibitable, active urea secretion in rabbit proximal straight tubules (74); (3) sodium-independent and/or phloretin-inhibitable active urea transporters in the skins of Bufo bufo, Rana esculenta, Bufo viridis, and Bufo marinus (75,76,77,78,79); (4) active urea transport in tubules from dog (80, 81) and frog (82, 83); and (5) active urea transport in Saccharomyces cerevisiae (84).

We confirmed the existence of active urea transport by perfusing initial IMCD from rats fed a low (8%) protein diet for at least 3 wk and showing that a sodium-dependent, secondary active, urea reabsorptive transport mechanism was present that was not expressed in initial IMCD of rats fed a normal (18%) protein diet (85,86,87) (Figure 1). This “sodium-urea cotransporter” (Table 2) is: (1) inhibited by removing sodium from the lumen (but not from the bath), suggesting that it is located in the apical membrane; (2) inhibited when Na+/K+-ATPase is inhibited with either ouabain or removing bath potassium; (3) not inhibited by phloretin; (4) not stimulated by vasopressin; and (5) encoded by a longer mRNA than UT-A1 based on initial expression cloning studies (85,86,87,88).

Figure 1.
Figure 1.

Urea transporters along the inner medullary collecting duct (IMCD). Cells are shown from the inner-outer medullary border (IMCD1, top) to the papillary tip (IMCD3, bottom) (136, 137). The tubule lumen is shown on the right, and Na+/K+-ATPase is shown in the basolateral membrane on the left side of each cell. The arrows indicate facilitated urea transporters. The circles connecting two arrows indicate secondary active urea transporters. The solid symbols indicate urea transporters that are expressed in untreated rats. The dashed symbols indicate urea transporters that are not expressed in untreated rats but can be induced under various conditions. (Top) An IMCD1 cell showing a facilitated urea transporter that is induced in low-protein fed and hypercalcemic rats (85, 86, 120) and two inducible, Na+-dependent, active urea transport processes: (1) a Na+-urea “cotransporter” in the apical membrane of low-protein fed (87) or hypercalcemic (102) rats; and (2) a Na+-urea “anti-porter” in the basolateral membrane of furosemide-treated rats (89). (Middle) An IMCD2 cell showing a facilitated urea transporter (UT-A1) that is expressed in the apical membrane of untreated rats (4, 49) and is upregulated in furosemide-treated, adrenalectomized, and hypercalcemic rats (50, 98, 120), and a Na+-dependent, active urea “anti-porter” that can be induced in the apical membrane of water-diuretic rats (102). (Bottom) An IMCD3 cell showing a facilitated urea transporter (UT-A1) that is expressed in the apical membrane of untreated rats (4, 49) and is upregulated in low-protein fed, furosemide-treated, adrenalectomized, and hypercalcemic rats (50, 98, 102, 120), and a Na+-dependent, active urea “anti-porter” that is expressed in the apical membrane of untreated rats (4, 49, 90). This Na+-urea “anti-porter” is upregulated by water diuresis (90) and downregulated by a low-protein diet (102), furosemide (89), or hypercalcemia (102).

View this table:
Table 2.

Na+-dependent active urea transport mechanisms in IMCD subsegmentsa

Recently, we have found two additional active urea transporters in rat IMCD subsegments (Figure 1). One is an active urea reabsorptive transport process that is expressed in initial IMCD from furosemide-treated rats (89). This active urea reabsorption differs from the one expressed in low-protein fed rats (Table 2) since it is: (1) inhibited by removing sodium from the bath (but not from the perfusate); (2) stimulated by vasopressin; and (3) inhibited by phloretin or ouabain (89). These results suggest a sodium-dependent, secondary active, urea reabsorptive transport mechanism in the basolateral membrane of initial IMCD (89).

The other newly described transport process is active urea secretion in the deepest portion of rat terminal IMCD, IMCD3 (Figure 1) (90). Active urea secretion (Table 2) is: (1) inhibited by removing sodium from the tubule lumen (but not from the bath); (2) stimulated by vasopressin; and (3) inhibited by phloretin or ouabain (90). These results suggest a sodium-dependent, secondary active, urea secretory transport mechanism in the apical membrane of IMCD3.

Regulation Of Urea Transporters

Vasopressin

Adding vasopressin to the bath of a perfused rat terminal IMCD results in vasopressin binding to V2 receptors, stimulating adenylyl cyclase, generating cAMP, stimulating protein kinase A, and ultimately increasing facilitated urea transport by increasing the number of functional urea transporters (Vmax) without changing the transporter's affinity (Km) for urea (4, 30, 43, 44, 91). The time course for vasopressin-induced stimulation of urea permeability, and the time course after vasopressin withdrawal, each consist of two distinct phases: an initial 10-min period during which facilitated urea permeability increases or decreases rapidly, followed by a second 10- to 60-min period during which facilitated urea permeability changes slowly (43, 92, 93).

Adding vasopressin to the lumen of a perfused rat terminal IMCD results in vasopressin binding to luminal V2 receptors and an increase in facilitated urea transport (94). However, if vasopressin is added to the bath before it is added to the lumen, then luminal vasopressin decreases facilitated urea transport, suggesting that luminal vasopressin is a negative modulator of basolateral vasopressin (94).

Hyperosmolality

Increasing osmolality, either by adding NaCl or mannitol, increases facilitated urea permeability in perfused rat terminal IMCD independently of vasopressin (35, 44, 95). When osmolality is increased in the presence of vasopressin, they have additive stimulatory effects on facilitated urea permeability (35, 36, 44, 95). Kinetic studies show that hyperosmolality, like vasopressin, increases the Vmax rather than the Km for facilitated urea transport, and inhibitor studies show that phloretin and thiourea inhibit hyperosmolality-stimulated facilitated urea permeability (35). However, increases in intracellular calcium (96) and protein kinase C (97) mediate hyperosmolality-stimulated facilitated urea permeability, whereas increases in adenylyl cyclase mediate vasopressin-stimulated facilitated urea permeability (43). Thus, both hyperosmolality and vasopressin increase facilitated urea permeability acutely by increasing Vmax, but they do so via different second-messenger pathways.

Water Diuresis and Water Restriction

Vasopressin has a long-term regulatory effect on the collecting duct facilitated urea transporter UT-A1 (Table 3) (51, 98), but this effect differs from vasopressin's effect on AQP2 (56). Making rats water-diuretic for at least 3 d (to decrease endogenous vasopressin) increases the basal (no vasopressin) facilitated urea permeability in rat terminal IMCD (98); 1 d of water diuresis increased basal urea permeability in one study (98) but not in a second (99). In rat initial IMCD, water diuresis for 1 to 7 d had no effect on basal facilitated urea permeability (98). Water-restricting rats for 1 d (to increase endogenous vasopressin) has no effect on basal facilitated urea permeability in rat terminal IMCD (98, 99). However, at least 2 d of water restriction does increase basal facilitated urea permeability in initial IMCD (IMCD1) and IMCD3 (98). Increasing vasopressin, either by water restriction (to increase endogenous vasopressin) or by administering (exogenous) vasopressin to Brattleboro rats, decreases the abundance of both the 97- and 117-kD UT-A1 urea transporter proteins (51), consistent with the facilitated urea permeability measurements (98). Administering deamino-8-D-arginine vasopressin to Brattleboro rats also increases the abundance of the 55-kD UT-A2 protein in thin descending limbs (100).

View this table:
Table 3.

Summary of facilitated urea transport and UT-A1 protein in IMCD subsegments

Northern analysis shows no change in UT-A1 mRNA abundance during water diuresis or restriction (38, 41, 47), suggesting that the changes in facilitated urea transport and UT-A1 protein abundance are not regulated by transcription. However, UT-A2 mRNA abundance does decrease in the inner medulla of water-loaded (3 d) rats and increase in: (1) water-restricted (3 d) rats; (2) rats receiving deamino-8-D-arginine vasopressin, a V2-selective vasopressin agonist for 3 wk; and (3) Brattleboro rats treated with vasopressin for 1 wk (38, 41, 101). The physiologic meaning of these changes in UT-A2 mRNA abundance is unclear.

In addition to upregulating facilitated urea transport in terminal IMCD, water diuresis upregulates the sodium-dependent, active urea secretory transporter (Table 4) (90, 102). Active urea secretion is present in IMCD3 from normal rats (90). It is upregulated 200% in IMCD3 from water diuretic rats that are not given food and 500% in IMCD3 from water-diuretic rats given food ad libitum (90). In addition, water diuresis induces active urea secretion IMCD2 (Figure 1) (102). Water restriction does not alter active urea secretion in either terminal IMCD subsegment (90, 102). Active urea secretion is not present in initial IMCD, regardless of the rat's hydration status (102). These results suggest that active urea secretion in physiologically important during water diuresis and not during water restriction.

View this table:
Table 4.

Summary of active urea transport processes in IMCD subsegmentsa

Furosemide

Adding furosemide to the bath fluid of a perfused rat terminal IMCD inhibits vasopressin-stimulated facilitated urea permeability (103). However, treating rats for 3 to 7 d with furosemide significantly increases basal facilitated urea permeability in rat terminal IMCD (Table 3), but has no effect on basal facilitated urea permeability in initial IMCD (98). In addition, treating rats for 5 d increases the abundance of the 117-kD UT-A1 protein; the abundance of the 97-kD UT-A1 protein is unchanged (51). In contrast, treating rats with furosemide for 18 h or 8 d has no effect on UT-A1 mRNA abundance but decreases UT-A2 mRNA abundance (104). Thus, both water and furosemide diuresis increase basal facilitated urea permeability and the abundance of the 117-kD UT-A1 protein, but have no effect on UT-A1 mRNA abundance.

Unlike water diuresis, treating rats with furosemide for 3 to 5 d inhibits active urea secretion in IMCD3 (Table 4) and does not induce it in IMCD2 (90, 102). Furosemide treatment (3 to 5 d) also induces a sodium-dependent, active urea reabsorptive transporter in the basolateral membrane of rat initial IMCD (Table 2) (89). Rats lose weight during the first 3 to 5 d of furosemide treatment, but come back into balance after 7 d (89), similar to the response of people treated with furosemide (105,106,107). Consistent with this time course, the induced active urea reabsorption is decreased after 7 d of furosemide (compared to the value measured after 3 to 5 d of furosemide) (89), suggesting that this transporter is involved in the initial response and the subsequent adaptation to chronic furosemide administration.

Low-Protein Diet

Several studies show that maximal urinary concentrating ability is decreased in malnourished people and in humans and other mammals fed a low-protein diet (6, 70, 108,109,110,111,112). Interestingly, infusing urea restores urine-concentrating ability in low-protein fed humans and other mammals within 5 to 10 min (108, 113, 114). A low-protein diet has profound effects on inner medullary function, including: (1) reduction in the fractional excretion of urea; (2) reduction in maximum urine-concentrating ability; and (3) reversal of the normal inner medullary urea concentration gradient so that the maximum inner medullary urea concentration is at the base of the inner medulla rather than at the inner medullary (papillary) tip (6,108,109,110,111,112,113,114,115,116,117).

A low-protein diet also has profound effects on urea transport in IMCD (Table 3). Feeding rats an 8% protein diet for 2 wk results in: (1) induction of vasopressin-stimulated facilitated urea permeability in initial IMCD (40,85,86); (2) increases in basal and vasopressin-stimulated facilitated urea permeability in IMCD3 (102); and (3) increases in the 117-kD UT-A1 protein abundance in the inner medulla (51). In initial IMCD, the vasopressin-stimulated facilitated urea permeability that is induced by a low-protein diet is stimulated by hyperosmolality and inhibited by phloretin and thiourea (40,85). Thus, it has the same functional characteristics as the vasopressin-stimulated facilitated urea permeability that is normally expressed in terminal IMCD (40).

In contrast to rats fed a low-protein diet for 2 wk, rats fed a low-protein diet for 1 wk do not: (1) express vasopressin-stimulated facilitated urea permeability in initial IMCD (86); (2) have a reduction in the fractional excretion of urea (109); or (3) have a change in UT-A1 + UT-A2 + UT-A4 protein abundance in microdissected initial IMCD (37). Whether the mRNA abundance of any UT-A isoform changes in the inner medulla of low-protein fed rats is controversial (38,40,118).

Feeding rats a low-protein diet for 3 wk (Table 4): (1) induces sodium-dependent, active urea reabsorption in the apical membrane of initial IMCD (85,86,87); and (2) inhibits active urea secretion in IMCD3 and does not induce it in IMCD2 (85,102). Thus, both furosemide and a low-protein diet inhibit active urea secretion in IMCD3 and induce active urea reabsorption in initial IMCD (Table 4). However, a low-protein diet induces an apical membrane active urea reabsorptive mechanism, whereas furosemide induces a basolateral membrane active urea reabsorptive mechanism.

Hypercalcemia

Hypercalcemia reduces urine-concentrating ability in humans and rats (119,120,121). Although varying perfusate calcium between 0 and 5 mM has no effect on facilitated urea permeability in terminal IMCD from normocalcemic rats (122), terminal IMCD from hypercalcemic rats have significantly increased values of both basal and vasopressin-stimulated facilitated urea permeability (120). The abundance of the 97- and 117-kD UT-A1 proteins are also increased in the inner medullary tip of hypercalcemic rats, consistent with the functional increase (120).

In addition, vasopressin significantly increases facilitated urea permeability in initial IMCD from hypercalcemic rats (120). Hypercalcemia also induces active urea reabsorption in the apical membrane of initial IMCD and inhibits active urea secretion in IMCD3 (102). Thus, hypercalcemia and a low-protein diet induce similar changes in facilitated and active urea transporters in IMCD subsegments (Tables 3 and 4).

Glucocorticoids

Adrenalectomy increases basal and vasopressin-stimulated facilitated urea permeability in rat terminal IMCD and the abundance of both the 97- and 117-kD UT-A1 proteins in the inner medullary tip (Table 3), compared with either shamoperated rats or adrenalectomized rats receiving a physiologic replacement dose of dexamethasone (50). This result suggests that glucocorticoids increase the fractional excretion of urea (123) by decreasing the amount of UT-A1 protein and facilitated urea reabsorption in rat terminal IMCD (50).

To examine the relevance of glucocorticoid-mediated regulation of facilitated urea transport to a common pathophysiologic condition, rats with uncontrolled diabetes mellitus induced by streptozotocin were studied, since these rats have increased corticosterone production and urea excretion. The 97-kD UT-A1 protein was significantly reduced in the inner medullary tip of diabetic rats compared with control rats (Table 3) (124). Although these results suggest that the decrease in UT-A1 protein in the inner medullary tip is mediated by the diabetes-induced increase in glucocorticoids (124), the experiment was repeated using three groups of adrenalectomized rats: (1) adrenalectomy alone; (2) adrenalectomy plus streptozotocin; and (3) adrenalectomy plus streptozotocin plus replacement with a physiologic dose of glucocorticoid (124). There was no significant difference in UT-A1 protein abundance between the adrenalectomy and the adrenalectomy plus streptozotocin rats. However, UT-A1 protein was significantly reduced in the inner medullary tip of glucocorticoid-treated adrenalectomized rats given streptozotocin compared to control adrenalectomized rats given streptozotocin but not given glucocorticoids (124). Thus, glucocorticoids regulate the abundance of the 97-kD UT-A1 protein independently of insulin in diabetic rats (124).

Other Agents

Oxytocin binds to V2 receptors, increases cAMP production, and increases phloretin-inhibitable, facilitated urea permeability in rat terminal IMCD (125). Oxytocin-stimulated facilitated urea permeability is unchanged by 2 d of water restriction in rat IMCD2 (125).

Glucagon increases the fractional excretion of urea by 45% in rats (126,127), suggesting that glucagon has an effect on the tubular transport of urea. However, glucagon does not stimulate cAMP production in either initial or terminal IMCD (86,128), or change basal or vasopressin-stimulated facilitated urea permeability in terminal IMCD (86).

UT-A1, UT-A2, and UT-B1 urea transporter mRNA abundances are reduced 1 wk after 5/6 nephrectomy in the remnant kidney (129). At 5 wk after 5/6 nephrectomy, no UT-A1 or UT-B1 mRNA is detected by Northern analysis, and UT-A2 mRNA abundance is reduced by 95% (129).

Amphotericin-B inhibits vasopressin-stimulated, but not cAMP-stimulated, facilitated urea permeability in rat terminal IMCD (130). α2-Adrenergic agonists (clonidine, epinephrine) inhibit cAMP production and vasopressin-stimulated facilitated urea permeability in rat terminal IMCD (128,131). Atrial natriuretic factor (132) and insulin (133) have no effect on vasopressin-stimulated facilitated urea permeability in rat terminal IMCD. Finally, chlorpropamide stimulates basal facilitated urea permeability, but its effect on vasopressin-stimulated facilitated urea permeability has not been tested (134).

Summary of Studies of the Long-Term Regulation of Urea Transport

Basal facilitated urea permeability and UT-A1 protein abundance have been measured in the rat inner medulla in five conditions associated with a reduction in urine-concentrating ability: water diuresis, furosemide diuresis, low-protein diet, adrenalectomy, and hypercalcemia (Table 3). In all five conditions, basal facilitated urea permeability is increased in IMCD3 and the abundance of the 117- and/or 97-kD UT-A1 urea transporter proteins are increased in the inner medullary tip. Thus, these studies lead to the surprising finding that basal facilitated urea permeability and UT-A1 protein abundance are increased during in vivo conditions associated with a reduced urine concentrating ability. These findings may be the mechanism that explains that rapid increase in urine concentrating ability after urea infusion into malnourished or low-protein fed people (6,108,113,117): UT-A1 is upregulated during reductions in concentrating ability to prepare the IMCD to rapidly restore inner medullary urea once urea (or protein) intake is restored.

In contrast to the single response pattern of facilitated urea transport, there are two response patterns of active urea transporters to reductions in urine concentrating ability (Table 4): (1) hypercalcemia, a low-protein diet, and furosemide result in induction of active urea reabsorption in initial IMCD, albeit by different mechanisms, and inhibition of active urea secretion in IMCD3; whereas (2) water diuresis results in upregulation of active urea secretion in IMCD3 and its induction in IMCD2, without any active urea reabsorption in initial IMCD. In the first response pattern, the induction of active urea reabsorption in initial IMCD contributes to the urine concentrating defect by increasing urea delivery to the base of the inner medulla, thus decreasing urea delivery to the inner medullary tip; the accompanying inhibition of active urea secretion in IMCD3 prevents an even further reduction in urea content in the deep inner medulla. In the second response pattern, the upregulation of active urea secretion in terminal IMCD will directly decrease urea content in the deep inner medulla.

Acknowledgments

Acknowledgments

This work was supported by National Institutes of Health Grants R01-DK41707 and P01-DK50268, and Grant-in-Aid 96006090 from the American Heart Association.

Footnotes

  • ↵ a For the 1998 ASN Gottschalk Symposium on Vasopressin-Regulated Transporters.

  • American Society of Nephrology

References

  1. ↵
    Kokko JP, Rector FC: Countercurrent multiplication system without active transport in inner medulla. Kidney Int2 : 214-223,1972
  2. ↵
    Stephenson JL: Concentration of urine in a central core model of the renal counterflow system. Kidney Int2 : 85-94,1972
  3. ↵
    Sands JM, Knepper MA: Urea permeability of mammalian inner medullary collecting duct system and papillary surface epithelium. J Clin Invest 79:138 -147, 1987
  4. ↵
    Sands JM, Nonoguchi H, Knepper MA: Vasopressin effects on urea and H2O transport in inner medullary collecting duct subsegments.Am J Physiol 253:F823 -F832, 1987
  5. ↵
    Macey RI, Yousef LW: Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol254 : C669-C674,1988
  6. ↵
    Gamble JL, McKhann CF, Butler AM, Tuthill E: An economy of water in renal function referable to urea. Am J Physiol109 : 139-154,1934
  7. ↵
    Galluci E, Micelli S, Lippe C: Non-electrolyte permeability across thin lipid membranes. Arch Int Physiol Biochim79 : 881-887,1971
  8. ↵
    Knepper MA, Roch-Ramel F: Pathways of urea transport in the mammalian kidney. Kidney Int 31:629 -633, 1987
  9. ↵
    Knepper MA, Star RA: The vasopressin-regulated urea transporter in renal inner medullary collecting duct. Am J Physiol259 : F393-F401,1990
  10. ↵
    Gillin AG, Sands JM: Urea transport in the kidney. Semin Nephrol 13: 146-154,1993
  11. ↵
    Sands JM, Timmer RT, Gunn RB: Urea transporters in kidney and erythrocytes. Am J Physiol 273:F321 -F339, 1997
  12. ↵
    Morgan T, Berliner RW: Permeability of the loop of Henle, vasa recta, and collecting duct to water, urea, and sodium. Am J Physiol 215: 108-115,1968
  13. ↵
    Morgan T, Sakai F, Berliner RW: In vitro permeability of medullary collecting duct to water and urea. Am J Physiol214 : 574-581,1968
  14. ↵
    Jaenike JR: The influence of vasopressin on the permeability of the mammalian collecting duct to urea. J Clin Invest40 : 144-151,1961
  15. ↵
    Morgan T: Permeability of the nephron to urea. In: Urea and the Kidney, edited by Schmidt-Nielsen B, Kerr DWS, Amsterdam, Excerpta Medica Foundation, 1970, p186
  16. ↵
    Rocha AS, Kudo LH: Water, urea, sodium, chloride, and potassium transport in the in vitro perfused papillary collecting duct. Kidney Int 22: 485-491,1982
  17. ↵
    Kondo Y, Imai M: Effects of glutaraldehyde fixation on renal tubular function. I. Preservation of vasopressin-stimulated water and urea pathways in rat papillary collecting duct.Pflügers Arch408 : 479-483,1987
  18. ↵
    Grantham JJ, Burg MB: Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules. Am J Physiol211 : 255-259,1966
  19. ↵
    Knepper MA: Urea transport in isolated thick ascending limbs and collecting ducts from rats. Am J Physiol245 : F634-F639,1983
  20. ↵
    Lory P, Gilg A, Horster M: Renal countercurrent system: Role of collecting duct convergence and pelvic urea predicted from a mathematical model. J Math Biol 16:281 -304, 1983
  21. ↵
    Bonventre JV, Lechene C: Renal medullary concentrating process: An integrative hypothesis. Am J Physiol239 : F578-F588,1980
  22. ↵
    Lory P: Effectiveness of a salt transport cascade in the renal medulla: Computer simulations. Am J Physiol252 : F1095-F1102,1987
  23. ↵
    Chandhoke PS, Saidel GM: Mathematical model of mass transport throughout the kidney: Effects of nephron heterogeneity and tubular-vascular organization. Ann Biomed Eng 9:263 -301, 1981
  24. ↵
    Chandhoke PS, Saidel GM, Knepper MA: Role of inner medullary collecting duct NaCl transport in urinary concentration. Am J Physiol 18: F688-F697,1985
  25. ↵
    Imai M, Taniguchi J, Tabei K: Function of thin loops of Henle.Kidney Int 31:565 -579, 1987
  26. ↵
    Sanjana VF, Robertson CR, Jamison RL: Water extraction from the inner medullary collecting tubule system: A role for urea. Kidney Int 10: 139-148,1976
  27. ↵
    Rocha AS, Kokko JP: Permeability of medullary nephron segments to urea and water: Effect of vasopressin. Kidney Int6 : 379-387,1974
  28. ↵
    Knepper MA, Sands JM, Chou C-L: Independence of urea and water transport in rat inner medullary collecting duct. Am J Physiol256 : F610-F621,1989
  29. ↵
    Chou C-L, Sands JM, Nonoguchi H, Knepper MA: Urea-gradient associated fluid absorption with σurea = 1 in rat terminal collecting duct. Am J Physiol 258:F1173 -F1180, 1990
  30. ↵
    Chou C-L, Knepper MA: Inhibition of urea transport in inner medullary collecting duct by phloretin and urea analogues. Am J Physiol 257:F359 -F365, 1989
  31. ↵
    You G, Smith CP, Kanai Y, Lee W-S, Stelzner M, Hediger MA: Cloning and characterization of the vasopressin-regulated urea transporter.Nature 365:844 -847, 1993
  32. ↵
    Fushimi K, Sasaki S, Yamamoto T, Hayashi M, Furokawa T, Uchida S, Kuwahara M, Ishibashi K, Kawasaki M, Kihara I, Marumo F: Functional characterization and cell immunolocalization of AQP-CD water channel in kidney collecting duct. Am J Physiol 267:F573 -F582, 1994
  33. ↵
    Macey RI, Farmer REL: Inhibition of water and solute permeability in human red cells. Biochim Biophys Acta211 : 104-106,1970
  34. ↵
    Macey RI: Transport of water and urea in red blood cells. Am J Physiol 246:C195 -C203, 1984
  35. ↵
    Gillin AG, Sands JM: Characteristics of osmolarity-stimulated urea transport in the rat IMCD. Am J Physiol262 : F1061-F1067,1992
  36. ↵
    Chou C-L, Sands JM, Nonoguchi H, Knepper MA: Concentration dependence of urea and thiourea transport pathway in rat inner medullary collecting duct. Am J Physiol 258:F486 -F494, 1990
  37. ↵
    Kishore BK, Terris J, Fernandez-Llama P, Knepper MA: Ultramicro-determination of vasopressin-regulated renal urea transporter protein in microdissected renal tubules. Am J Physiol272 : F531-F537,1997
  38. ↵
    Smith CP, Lee W-S, Martial S, Knepper MA, You G, Sands JM, Hediger MA: Cloning and regulation of expression of the rat kidney urea transporter (rUT2). J Clin Invest 96:1556 -1563, 1995
  39. ↵
    Olivès B, Martial S, Mattei MG, Matassi G, Rousselet G, Ripoche P, Cartron JP, Bailly P: Molecular characterization of a new urea transporter in the human kidney. FEBS Lett 386: 156-160,1996
  40. ↵
    Ashkar ZM, Martial S, Isozaki T, Price SR, Sands JM: Urea transport in initial IMCD of rats fed a low-protein diet: Functional properties and mRNA abundance. Am J Physiol 268:F1218 -F1223, 1995
  41. ↵
    Promeneur D, Rousselet G, Bankir L, Bailly P, Cartron JP, Ripoche P, Trinh-Trang-Tan MM: Evidence for distinct vascular and tubular urea transporters in the rat kidney. J Am Soc Nephrol7 : 852-860,1996
  42. ↵
    Martial S, Olives B, Abrami L, Couriaud C, Bailly P, You G, Hediger MA, Cartron J-P, Ripoche P, Rousselet G: Functional differentiation of the human red blood cell and kidney urea transporters. Am J Physiol271 : F1264-F1268,1996
  43. ↵
    Star RA, Nonoguchi H, Balaban R, Knepper MA: Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J Clin Invest81 : 1879-1888,1988
  44. ↵
    Sands JM, Schrader DC: An independent effect of osmolality on urea transport in rat terminal IMCDs. J Clin Invest88 : 137-142,1991
  45. ↵
    Shayakul C, Steel A, Hediger MA: Molecular cloning and characterization of the vasopressin-regulated urea transporter of rat kidney collecting ducts. J Clin Invest 98:2580 -2587, 1996
  46. ↵
    Karakashian A, Timmer RT, Klein JD, Gunn RB, Sands JM, Bagnasco SM: Cloning and characterization of two new mRNA isoforms of the rat renal urea transporter: UT-A3 and UT-A4. J Am Soc Nephrol10 : X-X,1999
  47. ↵
    Shayakul C, Knepper MA, Smith CP, DiGiovanni SR, Hediger MA: Segmental localization of urea transporter mRNAs in rat kidney. Am J Physiol 272:F654 -F660, 1997
  48. ↵
    Naruse M, Karakashian A, Nakayama Y, Sands JM, Bagnasco SM: The gene encoding the rat renal urea transporter (UT-A) has an internal promoter, which may control expression of UT-A2 [Abstract]. J Am Soc Nephrol 8: 23A,1997
  49. ↵
    Nielsen S, Terris J, Smith CP, Hediger MA, Ecelbarger CA, Knepper MA: Cellular and subcellular localization of the vasopressin-regulated urea transporter in rat kidney. Proc Natl Acad Sci USA93 : 5495-5500,1996
  50. ↵
    Naruse M, Klein JD, Ashkar ZM, Jacobs JD, Sands JM: Glucocorticoids downregulate the rat vasopressin-regulated urea transporter in rat terminal inner medullary collecting ducts. J Am Soc Nephrol8 : 517-523,1997
  51. ↵
    Terris J, Ecelbarger CA, Sands JM, Knepper MA: Long-term regulation of collecting duct urea transporter proteins in rat. J Am Soc Nephrol 9: 729-736,1998
  52. ↵
    Rouillard P, Klein JD, Timmer RT, Sands JM: Glycosylated forms of UT-A urea transporters present in kidney medulla [Abstract]. J Am Soc Nephrol 9: 25A,1998
  53. ↵
    Bagnasco SM, Jacobs JD, Timmer RT, Klein JD, Fröhlich O, Gunn RB, Sands JM: Immunolocalization of urea transporter proteins in human and rat kidney [Abstract]. FASEB J 11:A24 , 1997
  54. ↵
    Star RA: Apical membrane limits urea permeation across the rat inner medullary collecting duct. J Clin Invest86 : 1172-1178,1990
  55. ↵
    Wade JB, Terris J, Ecelbarger CA, Bradford AD, Knepper MA: Immunolocalization of urea transporter isoforms in rat inner medulla [Abstract]. J Am Soc Nephrol 9:27A , 1998
  56. ↵
    Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW: Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA90 : 11663-11667,1993
  57. ↵
    Terris J, Inoue T, Chou C-L, Lee AJ, Bradford AD, Ecelbarger CA, Nielsen S, Knepper MA: Vasopressin regulates aquaporin-2 and the vasopressin-regulated urea transporter (VRUT) by different short-term mechanisms [Abstract]. J Am Soc Nephrol8 : 26A,1997
  58. ↵
    Verbavatz J-M, Leroy C, Gobin R, Couriaud C, Berthonaud V, Ripoche P, Rousselet G: Evidence for vesicle trafficking regulation of urea permeability by ADH in amphibian urinary bladder [Abstract]. J Am Soc Nephrol 8: 27A,1997
  59. ↵
    Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P: Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 269:31649 -31652, 1994
  60. ↵
    Couriaud C, Ripoche P, Rousselet G: Cloning and functional characterization of a rat urea transporter: Expression in the brain.Biochim Biophys Acta 1309:197 -199, 1996
  61. ↵
    Tsukaguchi H, Shayakul C, Berger UV, Tokui T, Brown D, Hediger MA: Cloning and characterization of the urea transporter UT3: Localization in rat kidney and testis. J Clin Invest 99:1506 -1515, 1997
  62. ↵
    Xu Y, Olives B, Bailly P, Fischer E, Ripoche P, Ronco P, Cartron J-P, Rondeau E: Endothelial cells of the kidney vasa recta express the urea transporter HUT11. Kidney Int 51:138 -146, 1997
  63. ↵
    Pallone TL, Work J, Myers RL, Jamison RL: Transport of sodium and urea in outer medullary descending vasa recta. J Clin Invest93 : 212-222,1994
  64. ↵
    Pallone TL: Characterization of the urea transporter in outer medullary descending vasa recta. Am J Physiol267 : R260-R267,1994
  65. ↵
    Pallone TL, Nielsen S, Silldorff EP, Yang S: Diffusive transport of solute in the rat medullary microcirculation. Am J Physiol269 : F55-F63,1995
  66. ↵
    Olivès B, Mattei M-G, Huet M, Neau P, Martial S, Cartron J-P, Bailly P: Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 270: 15607-15610,1995
  67. ↵
    Lucien N, Sidoux-Walter F, Olivès B, Moulds J, Le Pennec PY, Cartron JP, Bailly P: Characterization of the gene encoding the human Kidd blood group urea transporter protein: Evidence for splice site mutations in Jknull individuals. J Biol Chem 273: 12973-12980,1998
  68. ↵
    Fröhlich O, Macey RI, Edwards-Moulds J, Gargus JJ, Gunn RB: Urea transport deficiency in Jk(a-b-) erythrocytes.Am J Physiol 260:C778 -C783, 1991
  69. ↵
    Sands JM, Gargus JJ, Fröhlich O, Gunn RB, Kokko JP: Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J Am Soc Nephrol2 : 1689-1696,1992
  70. ↵
    Lassiter WE, Mylle M, Gottschalk CW: Micropuncture study of urea transport in rat renal medulla. Am J Physiol210 : 965-970,1966
  71. ↵
    Danielson RA, Schmidt-Nielsen B: Recirculation of urea analogs from renal collecting ducts of high- and low-protein-fed rats. Am J Physiol 223: 130-137,1972
  72. ↵
    Ullrich KJ, Rumrich G, Schmidt-Nielsen B: Urea transport in the collecting duct of rats on normal and low protein diet.Pflügers Arch295 : 147-156,1967
  73. ↵
    Schmidt-Nielsen B, Truniger B, Rabinowitz L: Sodium-linked urea transport by the renal tubule of the spiny dogfish Squalus acanthias.Comp Biochem Physiol [A] 42A:13 -25, 1972
  74. ↵
    Kawamura S, Kokko JP: Urea secretion by the straight segment of the proximal tubule. J Clin Invest 58:604 -612, 1976
  75. ↵
    Ussing H, Johnansen B: Anomalous transport of sucrose and urea in toad skin. Nephron 6:317 -328, 1969
  76. ↵
    Garcia-Romeu F, Masoni A, Isaia J: Active urea transport through isolated skins of frog and toad. Am J Physiol241 : R114-R123,1981
  77. ↵
    Lacoste I, Dunel-Erb S, Harvey BJ, Laurent P, Ehrenfeld J: Active urea transport independent of H+ and Na+ transport in frog skin epithelium. Am J Physiol 261:R898 -R906, 1991
  78. ↵
    Rapoport J, Abuful A, Chaimovitz C, Noeh Z, Hays RM: Active urea transport by the skin of Bufo viridis: Amiloride- and phloretin-sensitive transport sites. Am J Physiol255 : F429-F433,1988
  79. ↵
    Dytko G, Smith PL, Kinter LB: Urea transport in toad skin (Bufo marinus). J Pharmacol Exp Ther 267:364 -370, 1993
  80. ↵
    Beyer KH Jr, Gelarden RT: Active transport of urea by mammalian kidney. Proc Natl Acad Sci USA 85:4030 -4031, 1988
  81. ↵
    Goldberg M, Wojtczak AM, Ramirez MA: Uphill transport of urea in the dog kidney: Effects of certain inhibitors. J Clin Invest46 : 388-399,1967
  82. ↵
    Forster RP: Active cellular transport of urea by frog renal tubules. Am J Physiol 179:372 -377, 1954
  83. ↵
    Schmidt-Nielsen B, Shrauger CR: Handling of urea and related compounds by the renal tubules of the frog. Am J Physiol205 : 483-488,1963
  84. ↵
    ElBerry HM, Majumdar ML, Cunningham TS, Sumrada RA, Cooper TG: Regulation of the urea active transporter gene (DUR3) in Saccharomyces cerevisiae.J Bacteriol175 : 4688-4698,1993
  85. ↵
    Isozaki T, Verlander JW, Sands JM: Low protein diet alters urea transport and cell structure in rat initial inner medullary collecting duct.J Clin Invest 92:2448 -2457, 1993
  86. ↵
    Isozaki T, Gillin AG, Swanson CE, Sands JM: Protein restriction sequentially induces new urea transport processes in rat initial IMCDs.Am J Physiol 266:F756 -F761, 1994
  87. ↵
    Isozaki T, Lea JP, Tumlin JA, Sands JM: Sodium-dependent net urea transport in rat initial IMCDs. J Clin Invest94 : 1513-1517,1994
  88. ↵
    Sands JM, Martial S, Isozaki T: Active urea transport in the rat initial inner medullary collecting duct: Functional characterization and initial expression cloning. Kidney Int49 : 1611-1614,1996
  89. ↵
    Kato A, Sands JM: Active sodium-urea counter-transport is inducible in the basolateral membrane of rat renal initial inner medullary collecting ducts. J Clin Invest 102:1008 -1015, 1998
  90. ↵
    Kato A, Sands JM: Evidence for sodium-dependent active urea secretion in the deepest subsegment of the rat inner medullary collecting duct. J Clin Invest 101:423 -428, 1998
  91. ↵
    Stokes JB: Potassium secretion by the cortical collecting tubule: Relation to sodium absorption, luminal sodium concentration, and transepithelial voltage. Am J Physiol241 : F395-F407,1981
  92. ↵
    Wall SM, Suk Han J, Chou C-L, Knepper MA: Kinetics of urea and water permeability activation by vasopressin in rat terminal IMCD. Am J Physiol 262:F989 -F998, 1992
  93. ↵
    Nielsen S, Knepper MA: Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes. Am J Physiol 265:F204 -F213, 1993
  94. ↵
    Nonoguchi H, Owada A, Kobayashi N, Takayama M, Terada Y, Koike J, Ujiie K, Marumo F, Sakai T, Tomita K: Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts.J Clin Invest 96:1768 -1778, 1995
  95. ↵
    Kudo LH, César KR, Ping WC, Rocha AS: Effect of peritubular hypertonicity on water and urea transport of inner medullary collecting duct. Am J Physiol262 : F338-F347,1992
  96. ↵
    Gillin AG, Star RA, Sands JM: Osmolarity-stimulated urea transport in rat terminal IMCD: Role of intracellular calcium. Am J Physiol 265:F272 -F277, 1993
  97. ↵
    Kato A, Rouillard P, Klein JD, Lea JP, Sands JM: Angiotensin II increases vasopressin-stimulated facilitated urea transport in the rat terminal IMCD [Abstract]. J Am Soc Nephrol9 : 20A,1998
  98. ↵
    Kato A, Naruse M, Knepper MA, Sands JM: Long-term regulation of inner medullary collecting duct urea transport in rat. J Am Soc Nephrol 9: 737-745,1998
  99. ↵
    Lankford SP, Chou C-L, Terada Y, Wall SM, Wade JB, Knepper MA: Regulation of collecting duct water permeability independent of cAMP-mediated AVP response. Am J Physiol 261:F554 -F566, 1991
  100. ↵
    Wade JB, Lee AJ, Ecelbarger CA, Mitchell C, Bradford AD, Terris J, Kim G-H, Knepper MA: Regulation of urea transporter (UT-A2) abundance in thin descending limb by vasopressin [Abstract]. J Am Soc Nephrol9 : 28A,1998
  101. ↵
    Smith CP, Shayakul C, You G, Lee W-S, Martial S, Mackenzie HS, Sands JM, Knepper MA, Hediger MA: Molecular characterization and regulation of expression of the vasopressin-regulated urea transporter [Abstract]. J Am Soc Nephrol 6: 329,1995
  102. ↵
    Kato A, Sands JM: Urea transport processes are induced in rat IMCD subsegments when urine concentrating ability is reduced. Am J Physiol 276: F62-F71,1999
  103. ↵
    Kudo LH, Van Baak AA, Rocha AS: Effect of furosemide on water and urea transport in cortical and inner medullary collecting duct. Kidney Int 37: 1248-1255,1990
  104. ↵
    Trinh-Trang-Tan MM, Promeneur D, Bankir L: Effect of furosemide on gene expression of the rat vasopressin-dependent urea transporter (UT2) [Abstract]. J Am Soc Nephrol 7:1273 , 1996
  105. ↵
    Wilcox CS, Mitch WE, Kelly RA, Skorecki KL, Meyer TW, Friedman PA, Souney PF: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102:450 -458, 1983
  106. ↵
    Kelly RA, Wilcox CS, Mitch WE, Meyer TW, Souney PF, Rayment CM, Friedman PA: Response of the kidney to furosemide. II. Effect of captopril on sodium balance. Kidney Int 24:233 -239, 1983
  107. ↵
    Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, Rayment CM, Braun L, Colucci R, Loon NR: Na+, K+, and BP homeostasis in man during furosemide: Effects of prazocin and captopril.Kidney Int 31:135 -141, 1987
  108. ↵
    Levinsky NG, Berliner RW: The role of urea in the urine concentrating mechanism. J Clin Invest38 : 741-748,1959
  109. ↵
    Peil AE, Stolte H, Schmidt-Nielsen B: Uncoupling of glomerular and tubular regulations of urea excretion in rat. Am J Physiol258 : F1666-F1674,1990
  110. ↵
    Epstein FH, Kleeman CR, Pursel S, Hendrikx A: The effect of feeding protein and urea on the renal concentrating process. J Clin Invest 36: 635-641,1957
  111. ↵
    Klahr S, Alleyne GAO: Effects of chronic protein-calorie malnutrition on the kidney. Kidney Int3 : 129-141,1973
  112. ↵
    Hendrikx A, Epstein FH: Effect of feeding protein and urea on renal concentrating ability in the rat. Am J Physiol195 : 539-542,1958
  113. ↵
    Pennell JP, Sanjana V, Frey NR, Jamison RL: The effect of urea infusion on the urinary concentrating mechanism in protein-depleted rats.J Clin Invest 55:399 -409, 1975
  114. ↵
    Crawford JD, Doyle AP, Probst H: Service of urea in renal water conservation. Am J Physiol 196:545 -548, 1959
  115. ↵
    Schmidt-Nielsen B, Barrett JM, Graves B, Crossley B: Physiological and morphological responses of the rat kidney to reduced dietary protein.Am J Physiol 248:F31 -F42, 1985
  116. ↵
    Truniger B, Schmidt-Nielsen B: Intrarenal distribution of urea and related compounds: Effect of nitrogen intake. Am J Physiol207 : 971-978,1964
  117. ↵
    Wilson DR, Sonnenberg H: Urea reabsorption in the medullary collecting duct of protein-depleted young rats before and after urea infusion.Pflügers Arch393 : 302-309,1982
  118. ↵
    Hu MC, Bankir L, Trinh-Trang-Tan MM: Effect of dietary protein on mRNA expression of renal urea transporters: Role of antidiuretic hormone [Abstract]. J Am Soc Nephrol 8:18A , 1997
  119. ↵
    Levi M, Peterson L, Berl T: Mechanism of concentrating defect in hypercalcemia: Role of polydipsia and prostaglandins. Kidney Int 23: 489-497,1983
  120. ↵
    Sands JM, Flores FX, Kato A, Baum MA, Brown EM, Ward DT, Hebert SC, Harris HW: Vasopressin-elicited water and urea permeabilities are altered in the inner medullary collecting duct in hypercalcemic rats. Am J Physiol 274:F978 -F985, 1998
  121. ↵
    Galla JH, Booker BB, Luke RG: Role of the loop segment in the urinary concentrating defect of hypercalcemia. Kidney Int29 : 977-982,1986
  122. ↵
    Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW: An apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99:1399 -1405, 1997
  123. ↵
    Knepper MA, Danielson RA, Saidel GM, Johnston KH: Effects of dietary protein restriction and glucocorticoid administration on urea excretion in rats. Kidney Int 8:303 -315, 1975
  124. ↵
    Klein JD, Price SR, Bailey JL, Jacobs JD, Sands JM: Glucocorticoids mediate a decrease in the AVP-regulated urea transporter in diabetic rat inner medulla. Am J Physiol 273:F949 -F953, 1997
  125. ↵
    Chou C-L, DiGiovanni SR, Luther A, Lolait SJ, Knepper MA: Oxytocin as an antidiuretic hormone. II. Role of V2 vasopressin receptor.Am J Physiol 269:F78 -F85, 1995
  126. ↵
    Knepper MA, Gunter CV, Danielson RA: Effects of glucagon on renal function in protein-deprived rats. Surg Forum27 : 29-31,1976
  127. ↵
    Ahloulay M, Bouby N, Machet F, Kubrusly M, Coutaud C, Bankir L: Effects of glucagon on glomerular filtration rate and urea and water excretion. Am J Physiol 263:F24 -F36, 1992
  128. ↵
    Maeda Y, Terada Y, Nonoguchi H, Knepper MA: Hormone and autacoid regulation of cAMP production in rat IMCD subsegments. Am J Physiol 263:F319 -F327, 1992
  129. ↵
    Trinh-Trang-Tan M-M, Hu MC, Bankir L: Underexpression of the epithelial and vascular urea transporters in the remnant kidney following subtotal nephrectomy [Abstract]. J Am Soc Nephrol9 : 27A,1998
  130. ↵
    Yano Y, Monteiro JL, Seguro AC: Effect of amphotericin B on water and urea transport in the inner medullary collecting duct. J Am Soc Nephrol 5: 68-74,1994
  131. ↵
    Rouch AJ, Kudo LH: α2-Adrenergic-mediated inhibition of water and urea permeability in the rat IMCD. Am J Physiol 271:F150 -F157, 1996
  132. ↵
    Nonoguchi H, Sands JM, Knepper MA: Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest82 : 1383-1390,1988
  133. ↵
    Magaldi AJ, Cesar KR, Yano Y: Effect of insulin on water and urea transport in the inner medullary collecting duct. Am J Physiol266 : F394-F399,1994
  134. ↵
    Rocha AS, Ping WC, Kudo LH: Effect of chlorpropamide on water and urea transport in the inner medullary collecting duct. Kidney Int 39: 79-86,1991
  135. Davey S, Beach D: RACH2, a novel human gene that complements a fission yeast cell cycle checkpoint mutation. Mol Biol Cell6 : 1411-1421,1995
  136. ↵
    Madsen KM, Tisher CC: Structural-functional relationship along the distal nephron. Am J Physiol 250:F1 -F15, 1986
  137. ↵
    Madsen KM, Clapp WL, Verlander JW: Structure and function of the inner medullary collecting duct. Kidney Int34 : 441-454,1988
Back to top

In this issue

View Selected Citations (0)
Print
Download PDF
Email Article
Citation Tools
Request Permissions
Regulation of Renal Urea Transporters
JEFF M. SANDS
JASN Mar 1999, 10 (3) 635-646;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section